Brief: Allurion Announces Notification Of Issuance Of New U.S. Patents On Next-Generation Weight Loss Device For The Treatment Of Obesity
04/03/2025 21:09
March 4 (Reuters) - Allurion Technologies Inc ALUR.N: ALLURION ANNOUNCES NOTIFICATION OF ISSUANCE OF NEW U.S. PATENTS ON NEXT-GENERATION WEIGHT LOSS DEVICE FOR THE TREATMENT OF OBESITY Source text: ID:nBw29mbwwa Further company coverage: ALUR.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy